Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Laura, Scaramucci"'
Autor:
Giorgio Silvestrini, Paola Tatangelo, Laura Scaramucci, Germana Sfara, Francesco Bondanini, Pasquale Niscola, Paolo de Fabritiis, Roberto Palumbo
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 31, Iss 6, Pp 1445-1447 (2020)
Externí odkaz:
https://doaj.org/article/2ad59a36696d43a3b27c504384667f4a
Autor:
Enrico Montefusco, Laura Scaramucci, Michele Cedrone, Antonio Spadea, Raffaele Porrini, Francesca Spirito, Giuseppe Cimino, Massimo Breccia, Angela Rago, Nicoletta Villivà, Marco Montanaro, Roberto Latagliata, Francesca Paoloni, Ermina Baldacci, Cristina Santoro, Ambra Di Veroli, Barbara Anaclerico, Alessandro Andriani, Maria Gabriella Mazzucconi
Publikováno v:
European Journal of Haematology. 105:335-343
Background and aims Anagrelide is a drug effective in reducing platelet counts in essential thrombocythemia (ET) and Ph1-negative myeloproliferative neoplasms. The aim of this study was to evaluate the real-life use of anagrelide in patients with ET
Autor:
Laura Scaramucci, Pasquale Niscola, Massimiliano Palombi, Andrea Tendas, Marco Giovannini, Paolo De Fabritiis
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 1, Pp 77-78 (2016)
Externí odkaz:
https://doaj.org/article/03fd59b27e9b46f6b4080f9dfa62f28a
Autor:
Elisabetta Abruzzese, Stefano Fratoni, Roberto Palumbo Paolo de Fabritiis, Malgorzata Monika Trawinska, Laura Scaramucci, Massimiliano Palombi, Pasquale Niscola, Andrea Tendas, Marco Giovannini $Francesco #Bondanini
Publikováno v:
Saudi Journal of Medicine. :50-52
Autor:
andrea tendas, pasquale niscola, luca cupelli, laura scaramucci, marco giovannini, daniela piccioni, teresa dentamaro, alessio pio perrotti, paolo de fabritiis
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 1 (2014)
The outcome of myelodysplastic syndromes (MDS) depends on both progression to acute leukemia and complications development. During a 18-months observation period, non-toxic complications emerging in 48 outpatient MDS, of which 15 (31%) on active trea
Externí odkaz:
https://doaj.org/article/abcc4a98ba0d40df878770001270a3ae
Autor:
Paola Tatangelo, Giorgio Silvestrini, Pasquale Niscola, Germana Sfara, Francesco Bondanini, Laura Scaramucci, Roberto Palumbo, Paolo de Fabritiis
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 31, Iss 6, Pp 1445-1447 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e99f91586621710e5e1bd343d67e1cf9
https://hdl.handle.net/2108/318994
https://hdl.handle.net/2108/318994
Autor:
Andrea Tendas, Pasquale Niscola, Luca Cupelli, Laura Scaramucci, Marco Giovannini, Paolo de Fabritiis
Publikováno v:
Haematologica, Vol 97, Iss 7 (2012)
Externí odkaz:
https://doaj.org/article/a00ac4c66d6b4b16b83c548c69e8fa67
Publikováno v:
Expert Review of Hematology. 12:703-705
Autor:
Pasquale Niscola, Claudio Romani, Luca Cupelli, Laura Scaramucci, Andrea Tendas, Teresa Dentamaro, Sergio Amadori, Paolo de Fabritiis
Publikováno v:
Haematologica, Vol 92, Iss 2 (2007)
Mucosal barrier injury (mucositis) is a common complication of many treatments used in hematologic malignancies, affecting most patients whose neoplasms are treated with intensive chemotherapy, and virtually all those receiving myeloablative conditio
Externí odkaz:
https://doaj.org/article/978cbb6c934347b5a3ca53795b99f8ac
Autor:
Pasquale Niscola, Laura Scaramucci, Marco Giovannini, Andrea Tendas, Luca Cupelli, Alessio Pio Perroti, Paolo de Fabritiis
Publikováno v:
Annals of Saudi Medicine, Vol 32, Iss 3, Pp 322-323 (2012)
Externí odkaz:
https://doaj.org/article/f7c61e42b9484c05bdcdfc7d2e096351